Medtronic to Acquire Intersect ENT for $1.1B

By rw-admin | August 8, 2021 | Comments Off on Medtronic to Acquire Intersect ENT for $1.1B

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has entered into a definitive agreement with Intersect ENT (NASDAQ: XENT), a global ear, nose, and throat (ENT) medical technology leader dedicated to transforming patient care, in which Medtronic will acquire all outstanding shares of Intersect ENT for $28.25 per share in an all-cash…

Read More

TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs

By rw-admin | August 1, 2021 | Comments Off on TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs

TransMedics Group, Inc. (“TransMedics”), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its OCS™ Lung Solution for use in transplants using cold storage techniques. The solution, which is also cleared as a component…

Read More